The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class ...

The drug, Journavx, from Vertex Pharmaceuticals, reduced pain after surgery in clinical trials. Experts hope it can lead to fewer opioid prescriptions.

It was given to people who had acute surgical pain from either abdominoplasty, also known as a tummy tuck, or bunion surgery.

The approval of Axsome Therapeutics’ Symbravo for migraine with or without aura came alongside the greenlight for Vertex's non-opioid treatment Journavx.

The Vertex drug is a milestone after a long history of unsuccessful efforts to develop painkillers without the addictive potential of opioids.

The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under ...

Discover the latest trends in the business world, from Barnes and Noble's growth fueled by BookTok to the FDA's approval of a new nonopioid pain medication.

The US Food and Drug Administration signed off Thursday on the first new type of pain reliever to be approved in more than ...

The new non-opioid drug has been approved for the treatment of severe pain, such as that following surgery or an injury.

Journavx is designed to eliminate the risks of addiction and overdose associated with medications like Vicodin and OxyContin.

The Food and Drug Administration on Tuesday approved Journavx, the first drug in a new class of non-opioid pain medications, ...